Literature DB >> 20969928

The role of Stat5 transcription factors as tumor suppressors or oncogenes.

G Ferbeyre1, R Moriggl.   

Abstract

Stat5 is constitutively activated in many human cancers affecting the expression of cell proliferation and cell survival controlling genes. These oncogenic functions of Stat5 have been elegantly reproduced in mouse models. Aberrant Stat5 activity induces also mitochondrial dysfunction and reactive oxygen species leading to DNA damage. Although DNA damage can stimulate tumorigenesis, it can also prevent it. Stat5 can inhibit tumor progression like in the liver and it is a tumor suppressor in fibroblasts. Stat5 proteins are able to regulate cell differentiation and senescence activating the tumor suppressors SOCS1, p53 and PML. Understanding the context dependent regulation of tumorigenesis through Stat5 function will be central to understand proliferation, survival, differentiation or senescence of cancer cells. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20969928     DOI: 10.1016/j.bbcan.2010.10.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  60 in total

Review 1.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

2.  miR-590-5p, miR-219-5p, miR-15b and miR-628-5p are commonly regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukemia.

Authors:  Amanda J Favreau; Pradeep Sathyanarayana
Journal:  Leuk Res       Date:  2011-10-19       Impact factor: 3.156

3.  Dysregulation of janus kinases and signal transducers and activators of transcription in cancer.

Authors:  Ana P Costa-Pereira; Nair A Bonito; Michael J Seckl
Journal:  Am J Cancer Res       Date:  2011-06-22       Impact factor: 6.166

4.  Lactogens protect rodent and human beta cells against glucolipotoxicity-induced cell death through Janus kinase-2 (JAK2)/signal transducer and activator of transcription-5 (STAT5) signalling.

Authors:  N Guthalu Kondegowda; A Mozar; C Chin; A Otero; A Garcia-Ocaña; R C Vasavada
Journal:  Diabetologia       Date:  2012-03-03       Impact factor: 10.122

5.  Holo-retinol-binding protein and its receptor STRA6 drive oncogenic transformation.

Authors:  Daniel C Berry; Liraz Levi; Noa Noy
Journal:  Cancer Res       Date:  2014-09-18       Impact factor: 12.701

6.  The PLA2R1-JAK2 pathway upregulates ERRα and its mitochondrial program to exert tumor-suppressive action.

Authors:  A Griveau; G Devailly; L Eberst; N Navaratnam; B Le Calvé; M Ferrand; P Faull; A Augert; R Dante; J M Vanacker; D Vindrieux; D Bernard
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

Review 7.  DNA damage response is hijacked by human papillomaviruses to complete their life cycle.

Authors:  Shi-Yuan Hong
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

8.  Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors.

Authors:  Sahyun Pak; Wansuk Kim; Yunlim Kim; Cheryn Song; Hanjong Ahn
Journal:  J Cancer Res Clin Oncol       Date:  2019-08-10       Impact factor: 4.553

9.  Combined p53- and PTEN-deficiency activates expression of mesenchyme homeobox 1 (MEOX1) required for growth of triple-negative breast cancer.

Authors:  Mari Gasparyan; Miao-Chia Lo; Hui Jiang; Chang-Ching Lin; Duxin Sun
Journal:  J Biol Chem       Date:  2020-05-28       Impact factor: 5.157

10.  The Molecular Signatures Database (MSigDB) hallmark gene set collection.

Authors:  Arthur Liberzon; Chet Birger; Helga Thorvaldsdóttir; Mahmoud Ghandi; Jill P Mesirov; Pablo Tamayo
Journal:  Cell Syst       Date:  2015-12-23       Impact factor: 10.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.